Skip to content

Effects of hypercapnia on short-term outcomes and inflammatory markers in Intensive Care Unit patients with chronic obstructive pulmonary disease combined with severe community-acquired pneumonia

Effects of hypercapnia on short-term outcomes and inflammatory markers in Intensive Care Unit patients with chronic obstructive pulmonary disease combined with severe community-acquired pneumonia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100160
Enrollment
Unknown
Registered
2025-04-03
Start date
2023-10-21
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease with severe community-acquired pneumonia

Interventions

Hypocapnia group , normal blood capnia group , hypercapnia group :None

Sponsors

Shuangliu District First People’s Hospital, Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 100 Years

Inclusion criteria

Inclusion criteria: According to the guidelines, CAP is diagnosed as SCAP if it meets 1 major criterion or > = 3 minor criteria. Main Criteria: Requires endotracheal intubation for mechanical ventilation; Sepsis shock requires vasoactive therapy despite aggressive fluid resuscitation. Secondary Criteria: respiratory rate>=30 breaths/min; Arterial partial pressure of oxygen/inspired oxygen concentration=7.14 mmol/L; Systolic blood pressure < 90 mmHg (1 mmHg = 0.133 kPa) requiring aggressive fluid resuscitation. Due to the lack of pulmonary function test results in enrolled patients, the definition of COPD was obtained from the patient's clinical baseline data, and terms including "chronic obstructive pulmonary disease", "emphysema", and "chronic bronchitis" were used as an alternative diagnosis of COPD.

Exclusion criteria

Exclusion criteria: In addition to COPD and severe pneumonia, other respiratory diseases that can cause hypoxia, such as asthma, active tuberculosis, bronchiectasis, interstitial lung disease, pneumothorax, etc.; Prior presence of chronic organ or hematologic dysfunction; Malignancy; Ongoing treatment with immunosuppressant drugs; autoimmune diseases; HIV infection; Greater than or equal to 14 consecutive days of >=20 mg/day prednisolone acetate or equivalent doses of other glucocorticoids or recent receipt of a cumulative dose >of 600 mg of prednisolone acetate or equivalent doses of other glucocorticoids; Acute cardiovascular and cerebrovascular diseases in the past 1 month; Patients who have been hospitalized 2 weeks prior to admission.

Design outcomes

Primary

MeasureTime frame
C-reactive protein;28-day cumulative survival;Procalcitonin;fibrinogen;neutrophils;plasma D-dimer;

Secondary

MeasureTime frame
The need for invasive mechanical ventilation;Failure of noninvasive mechanical ventilation;

Countries

China

Contacts

Public ContactMu Shan

Shuangliu District First People’s Hospital, Chengdu

1247646346@qq.com+86 199 8127 0212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026